Baird Medical Investment (BDMD) Stock Analysis
NASDAQHealthcareMedical - Devices
What Baird Medical Investment does
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Key metrics
ETFs linked to BDMD
Broad-market and Healthcare sector ETFs an investor holding Baird Medical Investment is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how BDMD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BDMD in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Baird Medical Investment?
- Baird Medical Investment trades under the ticker BDMD on NASDAQ.
- Which exchange is BDMD listed on?
- BDMD is listed on NASDAQ.
- What sector does Baird Medical Investment operate in?
- Baird Medical Investment is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze BDMD in a portfolio?
- PortView shows BDMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.